MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome
- PMID: 10508286
- DOI: 10.1002/(sici)1522-2586(199909)10:3<267::aid-jmri7>3.0.co;2-y
MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome
Abstract
This article reviews the experience available to date on microcirculation assessment in cancer of the cervix including correlation studies of magnetic resonance (MR) microcirculatory parameters with histo-morphometric predictors and direct correlation with patient outcome. The data suggest that MR microcirculation parameters do not always correlate with histo-morphometric parameters, while there is evidence that MR parameters predict patients' treatment outcome. These observations raise the issue that perhaps the histo-morphometric parameters, accepted gold standards for tumor angiogenesis and prognostic factors, reflect anatomical information at a "static" single time point and may not always provide sufficient information on the "dynamic" microcirculation function of the tumor. MR microcirculation assessment reflects both anatomical and functional information and may provide this additional information on the "dynamic" angiogenic and metabolic status of a tumor. Therefore, assessment of tumor microcirculation may augment the individual risk profile in cervical cancer patients and has the potential to impact on therapy selection and treatment outcome.
Similar articles
-
Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.Cancer Res. 1998 Aug 15;58(16):3598-602. Cancer Res. 1998. PMID: 9721867
-
Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging.J Magn Reson Imaging. 1997 Jan-Feb;7(1):111-9. doi: 10.1002/jmri.1880070115. J Magn Reson Imaging. 1997. PMID: 9039600 Review.
-
Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.MAGMA. 1999 Mar;8(1):55-62. doi: 10.1007/BF02590636. MAGMA. 1999. PMID: 10383094
-
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.Clin Cancer Res. 1998 Oct;4(10):2305-12. Clin Cancer Res. 1998. PMID: 9796959
-
Fundamentals of quantitative dynamic contrast-enhanced MR imaging.Magn Reson Imaging Clin N Am. 2009 May;17(2):277-89. doi: 10.1016/j.mric.2009.01.007. Magn Reson Imaging Clin N Am. 2009. PMID: 19406359 Review.
Cited by
-
Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis.Br J Radiol. 2016 Sep;89(1065):20150887. doi: 10.1259/bjr.20150887. Epub 2016 Jun 24. Br J Radiol. 2016. PMID: 27340932 Free PMC article.
-
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.Hepatol Int. 2015 Apr;9(2):258-68. doi: 10.1007/s12072-014-9557-1. Epub 2014 Jul 26. Hepatol Int. 2015. PMID: 25788178 Clinical Trial.
-
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5638-43. doi: 10.1073/pnas.0611721104. Epub 2007 Mar 20. Proc Natl Acad Sci U S A. 2007. PMID: 17374720 Free PMC article.
-
Delineation and segmentation of cerebral tumors by mapping blood-brain barrier disruption with dynamic contrast-enhanced CT and tracer kinetics modeling-a feasibility study.Eur Radiol. 2008 Jan;18(1):143-51. doi: 10.1007/s00330-007-0726-7. Epub 2007 Aug 14. Eur Radiol. 2008. PMID: 17701183
-
Optimization of perfusion CT protocol for imaging of extracranial head and neck tumors.J Digit Imaging. 2009 Oct;22(5):437-48. doi: 10.1007/s10278-008-9122-3. Epub 2008 May 3. J Digit Imaging. 2009. PMID: 18454289 Free PMC article.